Introduction: Nepal started the first phase of COVID-19 vaccination for frontline healthcare workers in January 2021 with the ChAdOx1 nCoV-19 (COVISHIELD) vaccine. We conducted active surveillance of Adverse Effect Following Immunization (AEFI) after the first dose of the vaccine administered at one of the sentinel sites for vaccination, Patan Academy of Health Sciences (PAHS). Method: All the 5591 first dose ‘COVISHIELD’ vaccine recipients between 27 Jan -5 Feb 2021 at PAHS, were approached through phone calls to collect data on AEFI. Incidence of common AEFIs in different age groups, gender and those with previous history of COVID-19 were analyzed. Presence of any Adverse Events of Special Interest (AESI) were evaluated. Result: Out of 5591 vaccines recipient, 3991 (71.3%) responded to the phone call and AEFI was noted in 3394 (85.04%) of them. Minor AEFI was seen in 3391 (84.9%), severe Minor AEFI in 1 (0.02%) and Serious AEFI in 2 (0.05%). Out of 807 vaccine recipients with previous history of COVID-19, 709 (87.9%) had AEFI while of the 3184 with no past history of COVID-19, 2685 (84.3%) had AEFI. However, some of the systemic AEFIs were noted more frequently in those with past COVID-19 infection. A total of 1886 (55.6%) took self-medication for symptom relief, 278 (8.2%) took leave from work while 26 (0.76%) visited health facility for the AEFIs. Conclusion: Most AEFIs following the first dose of COVISHIELD vaccine were mild and resolved within a few days. Except for one case of anaphylaxis, no other AESI were encountered.
30 April 2022 in Journal of Patan Academy of Health Sciences
Introduction: Pfizer-BioNTec vaccine was started in Nepal for the age group of more than 12 y. This study was conducted to find out the adverse event following immunization with Pfizer-BioNTech vaccine against COVID-19 at Patan Academy of Health Sciences (PAHS). Method: This is a descriptive study conducted at PAHS from November to December 2021. The vaccine recipients were called over the phone after 72 h of receiving the vaccine to find out adverse events following immunization (AEFI). They were inquired about the list of pre-defined AEFI. Ethical approval was obtained. Result: A total of 1377(27.4%) individuals among 5014 receiving the first dose and 983(71.4%) of 1377 receiving the second dose were enrolled in the study. Vaccine recipients who had minor AEFI in the first dose were 462(33.6%) and in the second dose were 205(20.9%). Reported AEFI in both first and second dose was pain 377(27.4%) and 97(9.9%) respectively, followed by fever in 65(4.8%) and 91(9.3%) respectively. There were no severe AEFI reported in both doses of vaccination. The AEFI started within 24 h and subsided within 72 h. Conclusion: Minor AEFI of pain and fever was reported with the first and second dose of the Pfizer-BioNTech vaccine. There were no severe and serious AEFI reported in this study population.
22 January 2026 in Turkish Journal of Sports Medicine
Objective: Wearing a mask is recommended during COVID-19 outbreaks as a means of source control. However, controversies persist regarding wearing masks during exercise. This study aimed to assess the impact of surgical mask use on heart rate and oxygen saturation during the Chester Step Test (CST). Methods: This is a prospective crossover study involving 24 individuals (12 females and 12 males) aged 35.4 ± 3.9 years with prior ethical clearance obtained. All healthy participants underwent the CST with and without wearing the surgical mask. The CST comprised five stages, each lasting two minutes, progressively intensifying from low to vigorous levels. Measurements of heart rate, oxygen saturation using MIR Spirodoc, and perceived exertion based on the Borg Scale were obtained every two minutes throughout the exercise stages. Statistical analysis utilized the paired sample T-test and Wilcoxon signed-rank test. Results: Six females and three males couldn't complete up to stage V of the test. Wearing a surgical mask resulted in significant variations than without a mask. During CST, wearing a mask resulted in reduced oxygen saturation (mean ± SD) (94.8 ± 1.8 vs. 96.0 ± 1.9, p=0.01) in stage III, increased heart rate (123 ± 16 vs. 117 ± 14, p=0.02) in stage II, and higher perceived exertion on the Borg scale in stage II [Q2(Q1-Q3)] [8(7-9) vs. 7(7-8.8), p=0.01)], stage IV [12(10-13) vs. 11(10-12), p=0.03] and stage V [13(12-13) vs. 12(10-13), p=0.01]. Conclusion: Wearing surgical masks affected heart rate in stage II, oxygen saturation in stage III and perceived exertion in stage II, IV, and V during the Chester Step Test. These findings emphasize the potential impact of mask use on physiological responses during exercise.